BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yuan Y, Wang X, Xu X, Liu Y, Li C, Yang M, Yang Y, Ma Z. Evaluation of a Dual-Acting Antibacterial Agent, TNP-2092, on Gut Microbiota and Potential Application in the Treatment of Gastrointestinal and Liver Disorders. ACS Infect Dis 2020;6:820-31. [DOI: 10.1021/acsinfecdis.9b00374] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Du Y, Lu Y, Wang H, Wu Q. Recent development of small-molecular inhibitors against Clostridioides difficile infection. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105843] [Reference Citation Analysis]
2 Ma Z, He S, Yuan Y, Zhuang Z, Liu Y, Wang H, Chen J, Xu X, Ding C, Molodtsov V, Lin W, Robertson GT, Weiss WJ, Pulse M, Nguyen P, Duncan L, Doyle T, Ebright RH, Lynch AS. Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens. J Med Chem 2022. [PMID: 35175750 DOI: 10.1021/acs.jmedchem.1c02045] [Reference Citation Analysis]
3 Surur AS, Sun D. Macrocycle-Antibiotic Hybrids: A Path to Clinical Candidates. Front Chem 2021;9:659845. [PMID: 33996753 DOI: 10.3389/fchem.2021.659845] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhao Z, Ma X, Zhang R, Hu F, Zhang T, Liu Y, Han MH, You F, Yang Y, Zheng W. A novel liposome-polymer hybrid nanoparticles delivering a multi-epitope self-replication DNA vaccine and its preliminary immune evaluation in experimental animals. Nanomedicine 2021;35:102338. [PMID: 33197626 DOI: 10.1016/j.nano.2020.102338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Stephens LJ, Werrett MV, Sedgwick AC, Bull SD, Andrews PC. Antimicrobial innovation: a current update and perspective on the antibiotic drug development pipeline. Future Medicinal Chemistry 2020;12:2035-65. [DOI: 10.4155/fmc-2020-0225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Liu J, Xu Y, Jiang B. Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective. Front Cell Infect Microbiol 2021;11:586427. [PMID: 33692964 DOI: 10.3389/fcimb.2021.586427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Saravanan P, Dusthackeer VNA, Rajmani RS, Mahizhaveni B, Nirmal CR, Rajadas SE, Bhardwaj N, Ponnuraja C, Bhaskar A, Hemanthkumar AK, Ramachandran G, Tripathy SP. Discovery of a highly potent novel rifampicin analog by preparing a hybrid of the precursors of the antibiotic drugs rifampicin and clofazimine. Sci Rep 2021;11:1029. [PMID: 33441878 DOI: 10.1038/s41598-020-80439-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]